Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2253830rdf:typepubmed:Citationlld:pubmed
pubmed-article:2253830lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2253830lifeskim:mentionsumls-concept:C0599755lld:lifeskim
pubmed-article:2253830lifeskim:mentionsumls-concept:C0042373lld:lifeskim
pubmed-article:2253830lifeskim:mentionsumls-concept:C0015127lld:lifeskim
pubmed-article:2253830lifeskim:mentionsumls-concept:C1314792lld:lifeskim
pubmed-article:2253830lifeskim:mentionsumls-concept:C0026565lld:lifeskim
pubmed-article:2253830lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:2253830lifeskim:mentionsumls-concept:C0033522lld:lifeskim
pubmed-article:2253830lifeskim:mentionsumls-concept:C0205848lld:lifeskim
pubmed-article:2253830lifeskim:mentionsumls-concept:C0023973lld:lifeskim
pubmed-article:2253830pubmed:issue9lld:pubmed
pubmed-article:2253830pubmed:dateCreated1991-1-23lld:pubmed
pubmed-article:2253830pubmed:abstractTextThe 497 members of the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics have been followed for mortality from 1975 to 1987. During this period 92 patients died. The most common cause of death was myocardial infarction: 36 (39.1%) deaths, heart disease was responsible for 51.1% of deaths and all cardiovascular disease for 55.4%. Neoplastic disease accounted for 25% of the deaths and diabetic nephropathy for 5.4%. Age-standardised mortality rates were higher in men than in women in both Type 1 (insulin-dependent) diabetes and Type 2 (non-insulin-dependent) diabetes. Standardised mortality ratios for the first and second five year follow-up periods were higher for men than for women in Type 2 diabetes but were higher for women than men in Type 1. The results suggest that the female survival advantage seen in the general population may persist in Type 2 but not in Type 1 diabetes.lld:pubmed
pubmed-article:2253830pubmed:languageenglld:pubmed
pubmed-article:2253830pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2253830pubmed:citationSubsetIMlld:pubmed
pubmed-article:2253830pubmed:statusMEDLINElld:pubmed
pubmed-article:2253830pubmed:monthSeplld:pubmed
pubmed-article:2253830pubmed:issn0012-186Xlld:pubmed
pubmed-article:2253830pubmed:authorpubmed-author:JAINT CTClld:pubmed
pubmed-article:2253830pubmed:authorpubmed-author:JarrettR JRJlld:pubmed
pubmed-article:2253830pubmed:authorpubmed-author:FullerJ HJHlld:pubmed
pubmed-article:2253830pubmed:authorpubmed-author:HeadJJlld:pubmed
pubmed-article:2253830pubmed:authorpubmed-author:MorrishN JNJlld:pubmed
pubmed-article:2253830pubmed:authorpubmed-author:StevensL KLKlld:pubmed
pubmed-article:2253830pubmed:issnTypePrintlld:pubmed
pubmed-article:2253830pubmed:volume33lld:pubmed
pubmed-article:2253830pubmed:ownerNLMlld:pubmed
pubmed-article:2253830pubmed:authorsCompleteYlld:pubmed
pubmed-article:2253830pubmed:pagination538-41lld:pubmed
pubmed-article:2253830pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:meshHeadingpubmed-meshheading:2253830-...lld:pubmed
pubmed-article:2253830pubmed:year1990lld:pubmed
pubmed-article:2253830pubmed:articleTitleA prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: Causes and death rates.lld:pubmed
pubmed-article:2253830pubmed:affiliationUnit for Metabolic Medicine, United Medical School, (Guy's Campus), London, UK.lld:pubmed
pubmed-article:2253830pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2253830pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2253830pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2253830lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2253830lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2253830lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2253830lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2253830lld:pubmed